Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) EPS (Weighted Average and Diluted): 2018-2020

Historic EPS (Weighted Average and Diluted) for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $8.39.

  • Genmab A's EPS (Weighted Average and Diluted) rose 358.09% to $1.97 in Q2 2021 from the same period last year, while for Jun 2021 it was $4.20, marking a year-over-year increase of 141.80%. This contributed to the annual value of $8.39 for FY2020, which is 137.04% up from last year.
  • Latest data reveals that Genmab A reported EPS (Weighted Average and Diluted) of $8.39 as of FY2020, which was up 137.04% from $3.54 recorded in FY2019.
  • Genmab A's EPS (Weighted Average and Diluted)'s 5-year high stood at $8.39 during FY2020, with a 5-year trough of $2.62 in FY2018.
  • Over the past 3 years, Genmab A's median EPS (Weighted Average and Diluted) value was $3.54 (recorded in 2019), while the average stood at $4.85.
  • Data for Genmab A's EPS (Weighted Average and Diluted) shows a peak YoY skyrocketed of 137.04% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Genmab A's EPS (Weighted Average and Diluted) stood at $2.62 in 2018, then surged by 34.89% to $3.54 in 2019, then soared by 137.04% to $8.39 in 2020.